100 related articles for article (PubMed ID: 18687346)
1. Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment.
Mann A; Miksys S; Lee A; Mash DC; Tyndale RF
Neuropharmacology; 2008 Dec; 55(7):1147-55. PubMed ID: 18687346
[TBL] [Abstract][Full Text] [Related]
2. Chronic treatment with asenapine affects cytochrome P450 2D (CYP2D) in rat brain and liver. Pharmacological aspects.
Danek PJ; Bromek E; Haduch A; Daniel WA
Neurochem Int; 2021 Dec; 151():105209. PubMed ID: 34666077
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 2D (CYP2D) enzyme dysfunction associated with aging and serotonin deficiency in the brain and liver of female Dark Agouti rats.
Haduch A; Danek PJ; Kuban W; Pukło R; Alenina N; Gołębiowska J; Popik P; Bader M; Daniel WA
Neurochem Int; 2022 Jan; 152():105223. PubMed ID: 34780807
[TBL] [Abstract][Full Text] [Related]
4. Genetic analysis of the equine orthologues for human CYP2D6: unraveling the complexity of the CYP2D family in horses.
Scantamburlo G; Nofziger C; Paulmichl M; Vanoni S
Front Vet Sci; 2023; 10():1188633. PubMed ID: 37929279
[TBL] [Abstract][Full Text] [Related]
5. Complex gene expansion of the
Feng P; Liu Z
Ecol Evol; 2018 Nov; 8(22):11022-11030. PubMed ID: 30519424
[TBL] [Abstract][Full Text] [Related]
6. The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients.
Mann A; Miksys SL; Gaedigk A; Kish SJ; Mash DC; Tyndale RF
Neurobiol Aging; 2012 Sep; 33(9):2160-71. PubMed ID: 21958961
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 mediates dopamine formation in the brain in vivo.
Bromek E; Haduch A; Gołembiowska K; Daniel WA
J Neurochem; 2011 Sep; 118(5):806-15. PubMed ID: 21651557
[TBL] [Abstract][Full Text] [Related]
8. Age-related modifications in CYP-dependent drug metabolism: role of stress.
Konstandi M; Johnson EO
Front Endocrinol (Lausanne); 2023; 14():1143835. PubMed ID: 37293497
[TBL] [Abstract][Full Text] [Related]
9. The Engagement of Cytochrome P450 Enzymes in Tryptophan Metabolism.
Haduch A; Bromek E; Kuban W; Daniel WA
Metabolites; 2023 May; 13(5):. PubMed ID: 37233670
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic drug monitoring of atomoxetine in children and adolescents with attention-deficit/ hyperactivity disorder: a naturalistic study.
Ruppert K; Geffert C; Clement HW; Bachmann C; Haberhausen M; Schulz E; Fleischhaker C; Biscaldi-Schäfer M
J Neural Transm (Vienna); 2022 Jul; 129(7):945-959. PubMed ID: 35391568
[TBL] [Abstract][Full Text] [Related]
11. Sex, estrous cycle, and hormone regulation of CYP2D in the brain alters oxycodone metabolism and analgesia.
Arguelles N; Richards J; El-Sherbeni AA; Miksys S; Tyndale RF
Biochem Pharmacol; 2022 Apr; 198():114949. PubMed ID: 35143755
[TBL] [Abstract][Full Text] [Related]
12. Contribution of CYP2D6 Functional Activity to Oxycodone Efficacy in Pain Management: Genetic Polymorphisms, Phenoconversion, and Tissue-Selective Metabolism.
Deodhar M; Turgeon J; Michaud V
Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575542
[TBL] [Abstract][Full Text] [Related]
13. Alterations of Cytochrome P450s and UDP-Glucuronosyltransferases in Brain Under Diseases and Their Clinical Significances.
Sheng Y; Yang H; Wu T; Zhu L; Liu L; Liu X
Front Pharmacol; 2021; 12():650027. PubMed ID: 33967789
[TBL] [Abstract][Full Text] [Related]
14. The role of CYP2D in rat brain in methamphetamine-induced striatal dopamine and serotonin release and behavioral sensitization.
Stocco MR; El-Sherbeni AA; Zhao B; Novalen M; Tyndale RF
Psychopharmacology (Berl); 2021 Jul; 238(7):1791-1804. PubMed ID: 33649968
[TBL] [Abstract][Full Text] [Related]
15. Human CYP2D6 in the Brain Is Protective Against Harmine-Induced Neurotoxicity: Evidence from Humanized CYP2D6 Transgenic Mice.
Stocco MR; Tolledo C; Wadji FB; Gonzalez FJ; Miksys S; Tyndale RF
Mol Neurobiol; 2020 Nov; 57(11):4608-4621. PubMed ID: 32761352
[TBL] [Abstract][Full Text] [Related]
16. Human CYP2D6 Is Functional in Brain In Vivo: Evidence from Humanized CYP2D6 Transgenic Mice.
Tolledo C; Stocco MR; Miksys S; Gonzalez FJ; Tyndale RF
Mol Neurobiol; 2020 Jun; 57(6):2509-2520. PubMed ID: 32189192
[TBL] [Abstract][Full Text] [Related]
17. Circulating Extracellular Vesicles Containing Xenobiotic Metabolizing CYP Enzymes and Their Potential Roles in Extrahepatic Cells Via Cell-Cell Interactions.
Gerth K; Kodidela S; Mahon M; Haque S; Verma N; Kumar S
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817878
[TBL] [Abstract][Full Text] [Related]
18. β-Naphtoflavone and Ethanol Induce Cytochrome P450 and Protect towards MPP⁺ Toxicity in Human Neuroblastoma SH-SY5Y Cells.
Fernandez-Abascal J; Ripullone M; Valeri A; Leone C; Valoti M
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373287
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 2D6 and Parkinson's Disease: Polymorphism, Metabolic Role, Risk and Protection.
Ur Rasheed MS; Mishra AK; Singh MP
Neurochem Res; 2017 Dec; 42(12):3353-3361. PubMed ID: 28871472
[TBL] [Abstract][Full Text] [Related]
20. "Target-Site" Drug Metabolism and Transport.
Foti RS; Tyndale RF; Garcia KL; Sweet DH; Nagar S; Sharan S; Rock DA
Drug Metab Dispos; 2015 Aug; 43(8):1156-68. PubMed ID: 25986849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]